Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies

Harnessing the power of immune cells, especially T cells, to enhance anti-tumor activities has become a promising strategy in clinical management of hematologic malignancies. The emerging bispecific antibodies...

Source: Journal of Hematology and Oncology - May 3, 2021 Category: Hematology Authors: Zheng Tian, Ming Liu, Ya Zhang and Xin Wang Tags: Review Source Type: research